Table 1.
Functional Classification | Partners | Cells | Experimental Evidence | Functional Description | Ref. |
---|---|---|---|---|---|
Loop extrusion | Cohesion | ES cells, Jurkat cells |
Co-IP, Chip | binding to DNA and extruding loops | [10,11,12,13] |
WAPL | - | - | releasing cohesin from DNA templates | [14,15] | |
NIPBL | - | - | stimulating the ATPase activity of cohesin | [16] | |
Transcription | RNA polymerase II | HeLa cells, K562 cells |
Co-IP, Chip | regulating transcription and alternative splicing | [17,18] |
ES cell development | Oct4 | ES cells | Co-IP, Chip | regulating XCI by triggering X chromosome pairing and counting | [19] |
Wdr5 | ES cells | Co-IP, Chip | acting as a downstream target of CTCF, and maintaining ES cell pluripotency and somatic reprogramming | [20] | |
WIZ | ES cells | Co-IP, Chip | acting as a structural regulator of DNA loops, and maintaining ES cell pluripotency and embryonic development | [21,22,23] | |
TAF3 | ES cells | Co-IP, Chip | mediating long-range chromatin regulation, supporting ES cells differentiate into endoderm | [24] | |
Immune cell development | Oct-1 | Naive T cells | Co-IP, Chip | regulating naive T-cell differentiation to the Th17 lineage by mediating the contacts of the Th2 locus with the IL-17 locus | [25] |
TCF-1 | T cells | Chip | regulating early T-cell development by modulating the TAD boundary formation and long-range chromatin interactions | [26,27] | |
Arie | Medullary thymic epithelial cells | Co-IP, Chip | controlling immunological tolerance by promoting superenhancer–promoter loop formation | [28] | |
ZNF143 | Hematopoietic stem and progenitor cells | Co-IP, Chip | maintaining the integrity of mouse hematopoietic stem and progenitor cells by regulating CTCF-bound promoter–enhancer loops | [29,30,31,32] | |
LDB1 | MEL cells | Co-IP, Chip | mediating erythroid lineage-specific long-range enhancer interactions | [33] | |
Muscle cell development | MyoD | Muscle cells | Chip | forming distinct chromatin loops with CTCF, and building the unique 3D genome structure of muscle cells | [34,35,36,37,38] |
Multiple developmental processes | YY1 | ES cells, B cells, NPC cells | Co-IP, Chip | acting as a structural protein of the 3D genome, and mediating long-range DNA contacts | [39,40,41,42,43,44,45,46,47] |
YB-1 | Hela cells, | Co-IP, Chip | inhibiting c-myc transcription, and regulating the 5-HTT polymorphic intron 2 enhancer | [48,49] | |
SUZ12 | Schwann cells | Co-IP, Chip | suppressing the differentiation inhibitory-pathway in Schwann cells | [50] | |
Potential roles in development | MAZ | K562, HepG2, HeLa | Co-IP, Chip | acting as a structural proteins of the 3D genome, and stabilizing CTCF binding to DNA | [51] |
BHLHE40 | HeLa cells | Co-IP, Chip | regulating CTCF genome-wide distribution and long-range chromatin interactions | [52] | |
Kaiso | HeLa cells, | Co-IP, Chip | regulating CTCF insulator activity | [53] | |
RFX | Raji cells | Co-IP | regulating HLA-DRB1 and HLA-DQA1 gene transcription | [54,55] | |
CIITA | Raji cells | Co-IP | regulating HLA-DRB1 and HLA-DQA1 gene transcription | [54,55] | |
Chromatin remodeling process | H2A.Z | ES cells | Chip | modulating nucleosome unwrapping and CTCF binding sites | [56] |
CDH8 | HeLa cells | GST, Chip | regulating CTCF insulator function | [57] | |
BPTF | ES cells | Co-IP, Chip | participating in chromatin remodeling, and regulating Klf4 binding near CTCF sites | [58,59] | |
BRG1 | WiT49, HeLa | Co-IP, Chip | mediating long-range chromatin interactions | [60,61] | |
SIN3A | HeLa cells | GST, Chip | modulating the histone deacetylase activity of CTCF | [62] | |
Nuclear receptor | VDR | THP-1 | Chip | inducing 3D chromatin changes upon activation by 1,25(OH)2D3 | [63] |
ER | MCF-7 | Chip | inducing 3D chromatin changes upon estrogen activation | [64,65] | |
Liquid–liquid phase separation | RYBP | ES cells | Co-IP, Chip | mediating long-distance interactions between A compartment by phase separation, and regulating the pluripotency of ES cells | [66] |
Abbreviations: Co-IP, co-immunoprecipitation; GST, glutathione-S-transferase pull down assay; Chip, chromatin immunoprecipitation; CHART-seq, RNA target sequencing.